-
The Impact of Clinical Evidence on the Inclusion of Non-Small Cell Lung Cancer Drugs in Brazil's Supplementary Healthcare System
Sep 9, 2025, 16:22 PM -
A Comprehensive Assessment of Clinical Studies on Artificial Intelligence-Enabled Interventions: Uncovering Trends and Potential Implications
Sep 9, 2025, 16:22 PM -
Prevalence of Migraine in India: A Meta-Analysis Based on Diagnostic Criteria and Gender Differences
Sep 9, 2025, 16:22 PM -
Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review
Sep 9, 2025, 16:22 PM -
Length of Stay (LOS) and Associated Healthcare Resource Use (HCRU) for a First Infusion of Axi-cel or Lisocel in Second Line for Large B-cell Lymphoma in France: Differences Observed From Comprehensive Hospital Databases
Sep 9, 2025, 16:22 PM -
Cost-Minimization Analysis and Economic Impact in EGPA: Evidence From MANDARA
Sep 9, 2025, 16:22 PM -
Uncovering Gender Disparities in Secondary Care for Major Adverse Cardiovascular Events (MACE): Insights From the Hospital Episodes Statistics (HES) Database
Sep 9, 2025, 16:22 PM -
Effectiveness of Vonoprazan on Health-Related Quality of Life and Sleep Quality in Chinese Patients With Reflux Esophagitis: Post Hoc Analysis of the VIEW Study
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Pediatric and Adult Pneumococcal Conjugate Vaccine Strategies in Canada
Sep 9, 2025, 16:22 PM -
Diagnostic Odyssey of Patients With the Rare Immunodeficiency-Activated PI3 Kinase Delta Syndrome (APDS): Case Study With Expert Interviews and Patient Surveys
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization Before and After Cardiovascular Disease Diagnosis in the NHS: A Descriptive Cohort Study
Sep 9, 2025, 16:22 PM -
Cost of Illness Study: Cushing's Syndrome in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
We Hear What You Are Saying: The Development and Design of the Qualitative Interview Feedback Survey (QIFS) for Use in Qualitative Patient-Centered Outcomes Research Studies
Sep 9, 2025, 16:22 PM -
Site of Care Cost-Effectiveness of Axicabtagene Ciloleucel in Relapsed/Refractory Second-Line or Later Large B-cell Lymphoma in the United States: Analyses for Inpatient and Outpatient Infusion Settings
Sep 9, 2025, 16:22 PM -
Investigating Composite Response Definitions Based on Key Surrogate Markers for Predicting Clinical Outcomes in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Economic Outcomes in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) in the US: A Real-World Claims Database Analysis
Sep 9, 2025, 16:22 PM -
Get Real: A How-to Framework on Designing and Implementing a Regulatory and HTA-Grade External Comparator Study
Sep 9, 2025, 16:22 PM -
Discrete Event Simulation and Treatment Sequencing Cost-Effectiveness Model in Second-Line Highly Active Relapse Remitting Multiple Sclerosis for a NICE Multiple Technology Appraisal
Sep 9, 2025, 16:22 PM -
The Clinical Impact of Screening Blood Donations for Hepatitis E Virus in Catalonia
Sep 9, 2025, 16:22 PM
